![](https://endpts.com/wp-content/uploads/2019/04/morgan-stanley-tile-shutterstock.jpg)
To counter a lawsuit, Bristol-Myers outlines how the big Celgene buyout will shower $187M-plus on Morgan Stanley
Anyone looking to see why investment bankers love big time M&A so much should check out Bristol-Myers Squibb’s new SEC filing Thursday evening. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.